XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 02, 2022
Jul. 03, 2021
Cash flows from operating activities:    
Net income $ 324,695 $ 315,419
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 20,722 15,596
Deferred income taxes (12,523) 6,107
Depreciation 36,956 34,891
Amortization of intangibles 29,935 29,852
Acquired in-process research and development and other non-cash items 7,903  
Change in operating assets and liabilities:    
(Increase) decrease in accounts receivable (57,377) 18,985
Increase in inventories (65,070) (50,873)
Increase in other current assets (9,199) (10,600)
Increase in other assets 4,658 (9,263)
Increase (decrease) in accounts payable and other current liabilities (32,197) (35,328)
Increase in deferred revenue and customer advances 70,027 91,631
Decrease in other liabilities (63,667) (44,973)
Net cash provided by operating activities 254,863 361,444
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (74,746) (76,889)
Proceeds from sale of equity investment, net 5,646  
Payments for intellectual property licenses (4,897) (7,000)
Purchases of investments (10,959) (215,140)
Maturities and sales of investments 77,553 17,923
Net cash used investing activities (7,403) (281,106)
Cash flows from financing activities:    
Proceeds from debt issuances 105,000 500,000
Payments on debt (135,000) (250,000)
Payments of debt issuance costs   (3,637)
Proceeds from stock plans 30,914 45,036
Purchases of treasury shares (321,944) (341,507)
Proceeds from derivative contracts 10,849 1,917
Net cash used in financing activities (310,181) (48,191)
Effect of exchange rate changes on cash and cash equivalents (19,616) (8,786)
(Decrease) increase in cash and cash equivalents (82,337) 23,361
Cash and cash equivalents at beginning of period 501,234 436,695
Cash and cash equivalents at end of period $ 418,897 $ 460,056